325 related articles for article (PubMed ID: 33225787)
21. A Case of AML1/ETO Positive Child with Acute Myeloid Leukemia with Poor Prognosis.
Zhang X; Wu Y; Wang L; Li H; Li R
Clin Lab; 2023 Feb; 69(2):. PubMed ID: 36787564
[TBL] [Abstract][Full Text] [Related]
22. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
[TBL] [Abstract][Full Text] [Related]
23. AML1-ETO needs a partner: new insights into the pathogenesis of t(8;21) leukemia.
Kuchenbauer F; Feuring-Buske M; Buske C
Cell Cycle; 2005 Dec; 4(12):1716-8. PubMed ID: 16294039
[TBL] [Abstract][Full Text] [Related]
24. UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8.
Fukuyama T; Kitamura T; Kozu T
Int J Hematol; 2022 May; 115(5):686-693. PubMed ID: 35152350
[TBL] [Abstract][Full Text] [Related]
25. t(8;21;14)(q22;q22;q24) is a novel variant of t(8;21) with chimeric transcripts of AML1-ETO in acute myelogenous leukemia.
Ishida F; Ueno M; Tanaka H; Makishima H; Suzawa K; Hosaka S; Hidaka E; Ishikawa M; Yamauchi K; Kitano K; Kiyosawa K
Cancer Genet Cytogenet; 2002 Jan; 132(2):133-5. PubMed ID: 11850074
[TBL] [Abstract][Full Text] [Related]
26. KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival.
Schnittger S; Kohl TM; Haferlach T; Kern W; Hiddemann W; Spiekermann K; Schoch C
Blood; 2006 Mar; 107(5):1791-9. PubMed ID: 16254134
[TBL] [Abstract][Full Text] [Related]
27. Translocation (8;17;15;21)(q22;q23;q15;q22) in acute myeloid leukemia (M2). a four-way variant of t(8;21).
Vieira L; Oliveira V; Ambrósio AP; Marques B; Pereira AM; Hagemeijer A; Boavida MG
Cancer Genet Cytogenet; 2001 Jul; 128(2):104-7. PubMed ID: 11463447
[TBL] [Abstract][Full Text] [Related]
28. Targeting miR-193a-AML1-ETO-β-catenin axis by melatonin suppresses the self-renewal of leukaemia stem cells in leukaemia with t (8;21) translocation.
Zhou B; Ye H; Xing C; Liang B; Li H; Chen L; Huang X; Wu Y; Gao S
J Cell Mol Med; 2019 Aug; 23(8):5246-5258. PubMed ID: 31119862
[TBL] [Abstract][Full Text] [Related]
29. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2.
Ahmad F; Kokate P; Chheda P; Dalvi R; Das BR; Mandava S
Cancer Genet Cytogenet; 2008 Jan; 180(2):153-7. PubMed ID: 18206543
[TBL] [Abstract][Full Text] [Related]
30. Relationships between AML1-ETO and MLL-AF9 fusion gene expressions and hematological parameters in acute myeloid leukemia.
Muddathir ARM; Hamid TAM; Mohamed Elamin E; Khabour OF
Gulf J Oncolog; 2020 Sep; 1(34):65-69. PubMed ID: 33431365
[TBL] [Abstract][Full Text] [Related]
31. CD7+ near-tetraploid acute myeloblastic leukemia M2 with double t(8;21)(q22;q22) translocations and Aml1/ETO rearrangements detected by fluorescence in situ hybridization analysis.
Yamamoto K; Nagata K; Kida A; Tsurukubo Y; Hamaguchi H
Int J Hematol; 2001 Oct; 74(3):316-21. PubMed ID: 11721969
[TBL] [Abstract][Full Text] [Related]
32. Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.
Dayyani F; Wang J; Yeh JR; Ahn EY; Tobey E; Zhang DE; Bernstein ID; Peterson RT; Sweetser DA
Blood; 2008 Apr; 111(8):4338-47. PubMed ID: 18258796
[TBL] [Abstract][Full Text] [Related]
33. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.
Miyamoto T; Nagafuji K; Akashi K; Harada M; Kyo T; Akashi T; Takenaka K; Mizuno S; Gondo H; Okamura T; Dohy H; Niho Y
Blood; 1996 Jun; 87(11):4789-96. PubMed ID: 8639850
[TBL] [Abstract][Full Text] [Related]
34. High expression of c-kit mRNA predicts unfavorable outcome in adult patients with t(8;21) acute myeloid leukemia.
Gao X; Lin J; Gao L; Deng A; Lu X; Li Y; Wang L; Yu L
PLoS One; 2015; 10(4):e0124241. PubMed ID: 25860287
[TBL] [Abstract][Full Text] [Related]
35. Simple variant t(8;21) acute myeloid leukemias harbor insertions of the AML1 or ETO genes.
Taviaux S; Brunel V; Dupont M; Fernandez F; Ferraz C; Carbuccia N; Sainty D; Demaille J; Birg F; Lafage-Pochitaloff M
Genes Chromosomes Cancer; 1999 Feb; 24(2):165-71. PubMed ID: 9885986
[TBL] [Abstract][Full Text] [Related]
36. RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.
Ptasinska A; Pickin A; Assi SA; Chin PS; Ames L; Avellino R; Gröschel S; Delwel R; Cockerill PN; Osborne CS; Bonifer C
Cell Rep; 2019 Sep; 28(12):3022-3031.e7. PubMed ID: 31533028
[TBL] [Abstract][Full Text] [Related]
37. AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches.
Hatlen MA; Wang L; Nimer SD
Front Med; 2012 Sep; 6(3):248-62. PubMed ID: 22875638
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the ETO and AML1-ETO proteins involved in 8;21 translocation in acute myelogenous leukemia.
Le XF; Claxton D; Kornblau S; Fan YH; Mu ZM; Chang KS
Eur J Haematol; 1998 Apr; 60(4):217-25. PubMed ID: 9579874
[TBL] [Abstract][Full Text] [Related]
39. Identification of ins(8;21) with AML1/ETO fusion in acute myelogenous leukemia M2 by molecular cytogenetics.
Urioste M; Martínez-Ramírez A; Cigudosa JC; Mateo MS; Martínez P; Contra T; Benítez J
Cancer Genet Cytogenet; 2002 Feb; 133(1):83-6. PubMed ID: 11890995
[TBL] [Abstract][Full Text] [Related]
40. Combined use of interferon alpha-1b, interleukin-2, and thalidomide to reverse the AML1-ETO fusion gene in acute myeloid leukemia.
Mi R; Chen L; Yang H; Zhang Y; Liu J; Yin Q; Wei X
Ann Hematol; 2021 Oct; 100(10):2593-2601. PubMed ID: 34312685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
